Adiponectin and Metabolic Syndrome in Women at Menopause.
Obesity is associated with premature atherosclerosis, as well as with many metabolic alterations including insulin resistance, dyslipidemia and hypertension. Visceral fat accumulation, particularly, is closely associated with the development of metabolic syndrome. The menopause transition, as well as the early postmenopausal period, is associated with increase in total and central obesity. Among adipocytokines secreted by the adipose tissue adiponectin is the only one that has a protective role in the development of obesity-related disorders, such as type 2 diabetes and cardiovascular disease. This review aims to present a role that adiponectin may play during the progress of menopause in relation to development of menopausal metabolic syndrome.
Deparment of Laboratory Medicine, Collegium Medicum in Bydgoszcz, Nicolas Copernicus University , Poland.
Aneta
A
Mankowska
Deparment of Laboratory Medicine, Collegium Medicum in Bydgoszcz, Nicolas Copernicus University , Poland.
Lena
L
Nowak
Deparment of Laboratory Medicine, Collegium Medicum in Bydgoszcz, Nicolas Copernicus University , Poland.
Grazyna
G
Sypniewska
adiponectin; menopause; metabolic syndrome; sex hormones
Curr Med Chem. 2007;14(27):2918-24
18045137
Int J Obes (Lond). 2007 Mar;31(3):457-65
16819528
Clin Chim Acta. 2008 Mar;389(1-2):45-50
18082632
J Clin Endocrinol Metab. 2005 Jan;90(1):175-80
15509644
Best Pract Res Clin Obstet Gynaecol. 2006 Dec;20(6):799-839
17084674
Pathol Biol (Paris). 2006 Sep;54(7):375-86
16904849
Eur J Endocrinol. 2008 Jun;158(6):889-97
18390991
Endocr Rev. 2005 May;26(3):439-51
15897298
Can J Physiol Pharmacol. 2007 Jan;85(1):113-32
17487251
Postepy Hig Med Dosw (Online). 2004;58:449-57
15599338
Obesity (Silver Spring). 2007 Sep;15(9):2217-24
17890489
Endokrynol Pol. 2006 Nov-Dec;57(6):626-32
17253436
Horm Res. 2003;60 Suppl 3:56-9
14671398
J Clin Endocrinol Metab. 2000 Jul;85(7):2378-84
10902782
Diabetes. 2006 Jun;55(6):1537-45
16731815
Diabetes. 2003 Apr;52(4):942-7
12663465
Przegl Lek. 2004;61(2):109-14
15230153
Gynecol Endocrinol. 2005 Apr;20(4):227-35
16019366
Eur J Endocrinol. 2006 Sep;155(3):429-34
16914597
Int J Obes (Lond). 2008 May;32(5):740-8
18180784
Ann Intern Med. 1995 Nov 1;123(9):673-5
7574222
J Clin Endocrinol Metab. 2004 Apr;89(4):1869-78
15070958
Diabetes Care. 2002 Jan;25(1):127-33
11772913
Eur J Endocrinol. 2004 Jul;151(1):135-40
15248834
J Clin Endocrinol Metab. 2002 Sep;87(9):4166-70
12213866
Endocrinology. 2006 Dec;147(12):5907-13
16990341
Maturitas. 2005 Jul 16;51(3):299-306
15978974
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):187-90
16232373
Endocr Rev. 2002 Feb;23(1):90-119
11844745
Atherosclerosis. 2007 Oct;194(2):e147-53
17239889
J Clin Endocrinol Metab. 2001 Jan;86(1):97-103
11231984
Acta Physiol Scand. 2005 Aug;184(4):285-93
16026420
Circ J. 2004 Nov;68(11):975-81
15502375
Menopause. 2008 May-Jun;15(3):536-41
18347511
Maturitas. 2008 May 20;60(1):10-8
18407440
Recent Prog Horm Res. 2002;57:257-75
12017547
Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):525-46
16311215
Clin Endocrinol (Oxf). 2007 Jan;66(1):65-71
17201803
Gynecol Endocrinol. 2005 Feb;20(2):68-73
15823824
Pol Merkur Lekarski. 2006 Jun;20(120):727-30
17007280
J Clin Invest. 2006 Jul;116(7):1784-92
16823476
Eur J Endocrinol. 2006 Oct;155(4):593-600
16990659
J Biomed Sci. 2008 Sep;15(5):565-76
18535923